Metropolitan Life Insurance CO Regeneron Pharmaceuticals, Inc. Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

63 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$902.69 - $993.35 $90,269 - $99,335	-100 Reduced 2.29%	4,261 $4.1 Million
Q4 2023 Feb 14, 2024	SELL	$775.18 - $881.7 $43,410 - $49,375	-56 Reduced 1.27%	4,361 $3.83 Million
Q3 2023 Nov 14, 2023	SELL	$692.45 - $844.37 $198,040 - $241,489	-286 Reduced 6.08%	4,417 $3.64 Million
Q2 2023 Aug 10, 2023	SELL	$700.03 - $830.35 $74,903 - $88,847	-107 Reduced 2.22%	4,703 $3.38 Million
Q1 2023 May 15, 2023	SELL	$680.49 - $826.97 $770,995 - $936,957	-1,133 Reduced 19.06%	4,810 $3.95 Million
Q4 2022 Jun 14, 2023	BUY	$705.89 - $766.39 $799,773 - $868,319	1,133 Added 23.56%	5,943 $4.29 Billion
Q4 2022 Mar 30, 2023	SELL	$705.89 - $766.39 $149,648 - $162,474	-212 Reduced 3.44%	5,943 $4.29 Million
Q4 2022 Feb 15, 2023	SELL	$705.89 - $766.39 $149,648 - $162,474	-212 Reduced 3.44%	5,943 $4.29 Million
Q3 2022 Jun 14, 2023	BUY	$573.97 - $724.32 $771,989 - $974,210	1,345 Added 27.96%	6,155 $4.24 Billion
Q3 2022 Mar 30, 2023	SELL	$573.97 - $724.32 $71,746 - $90,540	-125 Reduced 1.99%	6,155 $4.24 Million
Q3 2022 Nov 14, 2022	SELL	$573.97 - $724.32 $71,746 - $90,540	-125 Reduced 1.99%	6,155 $4.24 Million
Q2 2022 Jun 20, 2023	BUY	$548.35 - $738.84 $806,074 - $1.09 Million	1,470 Added 30.56%	6,280 $3.71 Million
Q2 2022 Mar 30, 2023	SELL	$548.35 - $738.84 $44,416 - $59,846	-81 Reduced 1.27%	6,280 $3.71 Million
Q2 2022 Aug 11, 2022	SELL	$548.35 - $738.84 $44,416 - $59,846	-81 Reduced 1.27%	6,280 $3.71 Million
Q1 2022 Jun 20, 2023	BUY	$595.12 - $698.43 $923,031 - $1.08 Million	1,551 Added 32.25%	6,361 $4.44 Million
Q1 2022 Mar 30, 2023	SELL	$595.12 - $698.43 $3.51 Million - $4.12 Million	-5,896 Reduced 48.1%	6,361 $4.44 Million
Q1 2022 May 12, 2022	SELL	$595.12 - $698.43 $3.51 Million - $4.12 Million	-5,896 Reduced 48.1%	6,361 $4.44 Million
Q4 2021 Jun 21, 2023	BUY	$543.48 - $670.97 $4.05 Million - $5 Million	7,447 Added 154.82%	12,257 $7.74 Million
Q4 2021 Mar 30, 2023	BUY	$543.48 - $670.97 $812,502 - $1 Million	1,495 Added 13.89%	12,257 $7.74 Million
Q4 2021 Feb 15, 2022	BUY	$543.48 - $670.97 $812,502 - $1 Million	1,495 Added 13.89%	12,257 $7.74 Million
Q3 2021 Jun 21, 2023	BUY	$574.03 - $680.96 $4.44 Million - $5.27 Million	7,734 Added 160.79%	12,544 $7.59 Million
Q3 2021 Mar 30, 2023	SELL	$574.03 - $680.96 $1.27 Million - $1.5 Million	-2,209 Reduced 17.03%	10,762 $6.51 Million
Q3 2021 Nov 15, 2021	SELL	$574.03 - $680.96 $1.27 Million - $1.5 Million	-2,209 Reduced 17.03%	10,762 $6.51 Million
Q2 2021 Jun 21, 2023	BUY	$472.8 - $558.54 $3.84 Million - $4.54 Million	8,126 Added 168.94%	12,936 $7.23 Million
Q2 2021 Mar 30, 2023	SELL	$472.8 - $558.54 $2.21 Million - $2.62 Million	-4,682 Reduced 26.52%	12,971 $7.24 Million
Q2 2021 Aug 16, 2021	BUY	$472.8 - $558.54 $6.12 Million - $7.23 Million	12,953 Added 71961.11%	12,971 $7.25 Million
Q1 2021 Jun 26, 2023	BUY	$446.73 - $548.2 $5.74 Million - $7.04 Million	12,843 Added 267.01%	17,653 $8.35 Billion
Q1 2021 Mar 30, 2023	SELL	$446.73 - $548.2 $441,369 - $541,621	-988 Reduced 5.3%	17,653 $8.35 Million
Q1 2021 May 14, 2021	SELL	$446.73 - $548.2 $8.32 Million - $10.2 Million	-18,623 Reduced 99.9%	18 $8.35 Million
Q4 2020 Jun 22, 2023	BUY	$478.3 - $607.98 $6.62 Million - $8.41 Million	13,831 Added 287.55%	18,641 $9.01 Million
Q4 2020 Mar 30, 2023	SELL	$478.3 - $607.98 $391,727 - $497,935	-819 Reduced 4.21%	18,641 $9.01 Million
Q4 2020 Feb 16, 2021	SELL	$478.3 - $607.98 $391,727 - $497,935	-819 Reduced 4.21%	18,641 $9.01 Million
Q3 2020 Jun 26, 2023	BUY	$544.75 - $658.21 $7.98 Million - $9.64 Million	14,650 Added 304.57%	19,460 $10.9 Million
Q3 2020 Mar 30, 2023	SELL	$544.75 - $658.21 $192,841 - $233,006	-354 Reduced 1.79%	19,460 $10.9 Million
Q3 2020 Nov 13, 2020	SELL	$544.75 - $658.21 $192,841 - $233,006	-354 Reduced 1.79%	19,460 $10.9 Million
Q2 2020 Jun 26, 2023	BUY	$493.32 - $643.92 $7.4 Million - $9.66 Million	15,004 Added 311.93%	19,814 $12.4 Million
Q2 2020 Mar 30, 2023	BUY	$493.32 - $643.92 $3.48 Million - $4.55 Million	7,059 Added 55.34%	19,814 $12.4 Million
Q2 2020 Aug 14, 2020	BUY	$493.32 - $643.92 $3.48 Million - $4.55 Million	7,059 Added 55.34%	19,814 $12.4 Million
Q1 2020 Jul 12, 2023	BUY	$336.18 - $494.43 $2.67 Million - $3.93 Million	7,945 Added 165.18%	12,755 $6.23 Million
Q1 2020 Mar 30, 2023	SELL	$336.18 - $494.43 $27,902 - $41,037	-83 Reduced 0.65%	12,755 $6.23 Million
Q1 2020 May 15, 2020	SELL	$336.18 - $494.43 $27,902 - $41,037	-83 Reduced 0.65%	12,755 $6.23 Million
Q4 2019 Jul 12, 2023	BUY	$274.13 - $376.51 $2.2 Million - $3.02 Million	8,028 Added 166.9%	12,838 $4.82 Million
Q4 2019 Mar 30, 2023	SELL	$274.13 - $376.51 $4,386 - $6,024	-16 Reduced 0.12%	12,838 $4.82 Million
Q4 2019 Feb 14, 2020	SELL	$274.13 - $376.51 $4,386 - $6,024	-16 Reduced 0.12%	12,838 $4.82 Million
Q3 2019 Jul 12, 2023	BUY	$273.46 - $318.39 $2.2 Million - $2.56 Million	8,044 Added 167.23%	12,854 $3.57 Million
Q3 2019 Mar 30, 2023	SELL	$273.46 - $318.39 $805,339 - $937,658	-2,945 Reduced 18.64%	12,854 $3.57 Million
Q3 2019 Nov 14, 2019	SELL	$273.46 - $318.39 $805,339 - $937,658	-2,945 Reduced 18.64%	12,854 $3.57 Million
Q2 2019 Jul 12, 2023	BUY	$299.6 - $414.82 $3.29 Million - $4.56 Million	10,989 Added 228.46%	15,799 $4.95 Million
Q2 2019 Mar 30, 2023	BUY	$299.6 - $414.82 $223,501 - $309,455	746 Added 4.96%	15,799 $4.95 Million
Q2 2019 Aug 14, 2019	BUY	$299.6 - $414.82 $223,501 - $309,455	746 Added 4.96%	15,799 $4.95 Million
Q1 2019 Jul 13, 2023	BUY	$372.08 - $439.57 $3.81 Million - $4.5 Million	10,243 Added 212.95%	15,053 $6.18 Million
Q1 2019 Mar 30, 2023	BUY	$372.08 - $439.57 $3.39 Million - $4 Million	9,110 Added 153.29%	15,053 $6.18 Million
Q1 2019 May 16, 2019	SELL	$372.08 - $439.57 $47.6 Million - $56.2 Million	-127,811 Reduced 89.46%	15,053 $6.18 Million
Q1 2019 May 15, 2019	BUY	$372.08 - $439.57 $47.4 Million - $56 Million	127,482 Added 828.77%	142,864 $5.05 Million
Q4 2018 Jul 13, 2023	BUY	$335.82 - $403.04 $3.55 Million - $4.26 Million	10,572 Added 219.79%	15,382 $5.75 Million
Q4 2018 Feb 14, 2019	BUY	$335.82 - $403.04 $11,753 - $14,106	35 Added 0.23%	15,382 $5.75 Million
Q3 2018 Jul 13, 2023	BUY	$351.14 - $408.51 $3.7 Million - $4.3 Million	10,537 Added 219.06%	15,347 $6.2 Billion
Q3 2018 Nov 14, 2018	SELL	$351.14 - $408.51 $118,685 - $138,076	-338 Reduced 2.15%	15,347 $6.2 Million
Q2 2018 Aug 15, 2018	BUY	$284.6 - $344.99 $50,374 - $61,063	177 Added 1.14%	15,685 $0
Q1 2018 May 15, 2018	BUY	$315.82 - $393.78 $29,371 - $36,621	93 Added 0.6%	15,508 $0
Q4 2017 Feb 15, 2018	SELL	$358.63 - $469.95 $8.76 Million - $11.5 Million	-24,438 Reduced 61.32%	15,415 $5.8 Million
Q3 2017 Nov 14, 2017	SELL	$431.38 - $504.0 $93,178 - $108,864	-216 Reduced 0.54%	39,853 $17.8 Million
Q2 2017 Aug 14, 2017	BUY	N/A	40,069	40,069 $19.7 Million

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account